Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment Trial Phase 1 Completed March 21, 2022
Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease Trial N/A Completed March 20, 2022
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease Trial Phase 1 Completed March 20, 2022
Effects of Routine Physical Therapy With and Without Proprioceptive Neuromuscular Facilitation on Balance, Gait and Function in Patients With Parkinson's Disease Trial N/A Completed March 17, 2022
Assessment of Transcranial Electrical Stimulation and Auditory Stimulation During Walking in Parkinson Patients Trial N/A Unknown March 17, 2022
Use and Misuse of Domperidone in Parkinson's Disease in France - Observational Trial N/A Terminated March 14, 2022
Lifestyle and Non-motor Symptom Management in Parkinson's Disease Trial N/A Terminated March 10, 2022
Role of Sleep on Motor Learning in Parkinson's Disease and Healthy Older Adults Trial N/A Unknown March 8, 2022
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants Trial Phase 2 Completed March 1, 2022
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants Trial Phase 3 Completed March 1, 2022
A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants Trial Phase 3 Completed March 1, 2022
Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism Trial Phase 2 Withdrawn March 1, 2022
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients Trial Phase 3 Completed March 1, 2022
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease Trial Phase 2 Terminated Feb. 27, 2022
Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing Trial N/A Completed Feb. 21, 2022